Nicotinic Modulation of Schizophrenia-like Information Processing Deficits in Healthy Subjects

NCT00690170 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Healthy Subjects

Interventions

DRUG: Ketamine
DRUG: Nicotine
DRUG: Placebo
DRUG: Ketamine and Nicotine

Sponsor

Yale University